Certified by Founder Lodge
ArteraAI
United States - Los Altos, California
START UP
1 Disclosed Funding Rounds $90,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our AI can prognosticate patient outcomes & personalize treatment in localized prostate cancer.
Five Phase III randomized trials were used to develop prognostic and predictive AI biomarker
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 27 ,2023 | Unknown | $90,000,000 | |
| February, 02 ,2024 | Unknown | $20,000,000.00 |
Rill Data
Google
Salesforce.org
Coatue
Koch Disruptive Technologies
Johnson & Johnson
Walden Catalyst Ventures
Breyer Capital
Factory
Hazel Health
LA Clippers
Stanford University
Patchwork Health
Abridge
Salvo Health
CareBridge
Health Note
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)